These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8797878)

  • 21. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
    Kobayashi H; Kawashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
    Miller K; Millar J; McCluggage WG
    Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C; Medl M; Ogris E; Leodolter S
    Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
    Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
    Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
    Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
    Fayed ST; Ahmad SM; Kassim SK; Khalifa A
    Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of tumor-associated CA-125 antigen in the diagnosis and monitoring of ovarian cancer].
    Ial'chenko NA; Levik NN; Musin II
    Akush Ginekol (Mosk); 1991 Sep; (9):61-2. PubMed ID: 1746705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes.
    Matsushita N; Ghazizadeh M; Konishi H; Araki T
    J Nippon Med Sch; 2003 Feb; 70(1):40-4. PubMed ID: 12646975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes].
    Nozawa S; Yajima M; Udagawa Y; Kiguchi K; Iizuka R; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1823-9. PubMed ID: 2687409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
    Novakovic S; Fras PA; Jezersek-Novakovic B
    In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of cell proliferation based on group analysis of Ki-67 index in serous ovarian cancers].
    Blok R; Blok K; Gryboś M; Klimkiewicz D; Jeleń-Krzeszewska J; Latkowski K
    Ginekol Pol; 2004 Oct; 75(10):776-84. PubMed ID: 15587909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer.
    Oehler MK; Sütterlin M; Caffier H
    Anticancer Res; 1999; 19(4A):2513-8. PubMed ID: 10470185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB; Goplerud DR; Kilpatrick SJ; Myers MB; Hunt A
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
    Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
    Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.